Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "OTC"

140 News Found

Bayer brings Alka-Seltzer to India touting first antacid with probiotic support
News | June 09, 2026

Bayer brings Alka-Seltzer to India touting first antacid with probiotic support

The launch comes against the backdrop of a significant public health burden


Akumentis Healthcare appoints Dharnendra Doshi as Senior Vice President
People | May 25, 2026

Akumentis Healthcare appoints Dharnendra Doshi as Senior Vice President

Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels


Zota Health Care posts 83.86% revenue surge in FY26
Healthcare | May 25, 2026

Zota Health Care posts 83.86% revenue surge in FY26

Expands Davaindia network to 2,579 stores


Cipla achieves highest-ever annual revenue of Rs. 28,163 crore in FY26
News | May 15, 2026

Cipla achieves highest-ever annual revenue of Rs. 28,163 crore in FY26

The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market


Dabur profit jumps 16% as FMCG growth gains pace
News | May 08, 2026

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine


Experts call for easing access to 2mg and 4mg nicotine replacement therapies
Public Health | May 07, 2026

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical


Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
Drug Approval | April 20, 2026

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry

The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation


Glenmark Therapeutics USA launches fluticasone propionate nasal spray
News | March 20, 2026

Glenmark Therapeutics USA launches fluticasone propionate nasal spray

The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million